ЭНДОТЕЛИАЛЬНАЯ ДИСФУНКЦИЯ И ОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ
Аннотация
Эндотелиальная дисфункция и острый коронарный синдром.
Об авторах
С. Д. Маянская
Новосибирская государственная медицинская академия, МЗРФ
Россия
Россия
Кафедра факультетской терапии
А. Д. Куимов
Новосибирская государственная медицинская академия, МЗРФ
Россия
Россия
Кафедра факультетской терапии
Список литературы
1. Афанасьев И.Б. Свободно-радикальные ингибиторы и промоторы в биологических процессах. – В кн.: Кислородные радикалы в химии, биологии и медицине, Рига, 1988. - С.9-25.
2. Грацианский Н.А. Нестабильная стенокардия – острый коронарный синдром. Некоторые новые факты о патогенезе и их значение для лечения // Кардиология.- 1996.-N.11.- C.4-15.
3. Денисенко А.Д., Виноградов А.Г., Пивоварова Ю.И. с соавт. Влияние блокады ретикулоэндотелиальной системы на метаболизм липопротеидов низкой плотности //Вопр. мед. химии.- 1993.-Т.39.-N.3.-С.6-8.
4. Жданов В.С. Некоторые актуальные вопросы патологической анатомии коронарного атеросклероза //Арх. патол.-1993.-N.2.-С.39-45.
5. Зильбер А.П. Медицина критических состояний. Общие проблемы.- Петрозаводск, 1995.-Т.1.- 357с.
6. Климов А.Н., Никульчева Н.Г. Обмен липидов и липопротеидов и его нарушения - Санкт-Петербург, 1999.-512с.
7. Куимов А.Д., Маянская С.Д., Барбарич В.Б. Антиоксидантная активность триметазидина в лечении острого инфаркта миокарда // Рос. кард. журнал, Мат. VI Всеросийского съезда кардиологов.- Москва.-1999.-N 4 (приложение).-С.83-84.
8. Маянский Д.Н., Маянская С.Д. Лейкоцитарные механизмы острого коронарного синдрома //Бюл.СОРАМН.-1998.-N.2.-С.41-45.
9. Маянский Д.Н., Урсов И.Г. Лекции по клинической патологии.-Новосибирск, 1997.- 249с.
10. Маянская С.Д. Воспалительные реакции при ишемической болезни сердца и подходы к их коррекции // Автореф. докт. дис., 1999.
11. Маянская С.Д., Маянская Н.Н., Куимов А.Д., Цырендоржиев Д.Д., Ефремов А.В. Функциональная активность лейкоцитов крови у больных нестабильной стенокардией и острым инфарктом миокарда. Перспективы исследования //Рос. кард. журнал.-1999.-N.5.- С.15-17.
12. РуксинВ. В. Тромбозы в кардиологической практике. – Санкт - Петербург, 1998. -126с.
13. Anker S.D., Ponikowski P.P., Clark A.L. et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure // Eur.Heart J.-1999.- V.20.-N.9.-p.683-694.
14. Aversano T., Zhou W., Nedelman M. et al. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion // J.Amm.Coll.Cardiol.-1995.-V.25.-p.781-7881.
15. Berk B.C. Weintraub W,S., Alexander R.W. Elevation of C-reactive protein in «active» coronary artery disease //Am. J.Cardiol.-1990.- N.65.-p.168-172.
16. Bevilacqua M.P., Pober J., Mendrick D. et al. Identification of an inducible endothelial-leukocyte adhesion molecule //Proc. Natl, Acad. Sci. USA. -1987.-V.84.-p.9238-9242.
17. Biasucci L., Vitelli A., Liuzzo G. et al. Elevated levels of interleukin- 6 in unstable angina // Circulation.- 1996.- 94.- p. 874-877.
18. Binns R.M., Licence S.T., Harrison A.A., Keelan E., Robinson M.,Haskard D. In vivo E-selectin upregulation correlates early with infiltration of PMN, later with PBL entry: MAвs block both // Am.J.Physiol.- Heart Circ. Physiol.- 1996.- 39.- p. H183- H193.
19. Blum A., Miller H. The Role of inflammation in atherosclerosis / /Israel J.Med.Sci.-1996.-V.32.-N.11.-p.1059-1065.
20. Bouma M.G., Vandenwildenberg F.A.J.M., Buurman W.A. Adenosine inhibits cytokine release and expression of adhesion molecults by activated human endothelial cells //Am.J.Physiol.- Cell.Physiol.-1996.-V.39.-N.2.-p.C522-C529.
21. Buerke M., Murohara T., Skurk C., Nuss C., Tomaselli K., Lefer A. Cardioprotective effect of insulin-like growth factor 1 in myocardial ischemia followed by reperfusion // Proc. Natl. Acad. Sci. USA.- 1995.- 92.- p. 8031-8035.
22. Bullough D., Magill M., Mullane K., Firestein G. Carbohydrate and CD18-dependent neutrophil adhesion to cardiac myocytes: effects of adenosine // Cardiovasc.Res.- 1996.- 32.-p.328-334.
23. Bult H. Nitric oxide and atherosclerosis: Possible implications for therapy //Molec. Med. Today.-1996.-V.2.-N.12.-p.510-518.
24. Burke S.E., Nelson R.A. Endothelin-receptor antagonist FR 139317 reduces infarct size in a rabbit model when given before, but not after, coronary artery occlusion //J.Cardiovasc.Pharmacol.-1997.- V.29.-N.1.-p.87-92.
25. Cannon C.P., McCabe C.H., Borzak S., Henry T.D. et al. Randomized trial of an oral platelеt glicoprotein IIb/IIIa antogonist, sibrafiban, in patients after an acute coronary syndrome // Circulation.-1998.-V.97.-p.340-349.
26. Carpenter K.L.H., Wilkins G.M., Fussell B. et al.Production of oxidised lipids during modification of low-density lipoprotein by macrophages or copper // Biochem J.-1994.-V.304.-p.625-633.
27. Cohen J.J. Overview: Mechanisms of apoptosis // Immunology today.-1993.-V.14.-N.3.-p.126-136.
28. Crea F., Biasucci L.M., Buffon A. et al. Role of inflammation in the pathogenesis of unstable coronary artery disease //Am.J.Cardiol.- 1997.-V.80.-N.4.-p.E10-E16.
29. Dabesh J., Muir J., Wong Y. et al. Risk factors for coronary heart disease and acute-phase proteins; a population-based study // Eur.Heart J.-1999.-V.20.-N.13.-p.954-960.
30. Danesh J., Collins R., Peto R. Cronic infections and coronary heart disease: is there a link? //Lancet.-1997.-V.350.-p.430-436.
31. Davies M.J., Richardsom P.D., Woolf N. et al. Risk of thrombosis in human atherosclerotic plaque: role of extracellular lipid, macrophage, and smooth muscle cell content //Br. Heart J.-1993.- V.69.-p.377-381.
32. Dayer J.M. Anti-cytokines. / Mononuclear Phagocytes, ed. by Ralph van Furth,1992.-p.375-380.
33. Deservi S., Mazzone A., Ricevuti G. et al. Clinical and angiographic correlates of leukocyte activation in unstable angina // J. Amer. College Cardiol.- 1995.- 26.- p.1146-1150.
34. Dinarello C.A. Controlling the production of interleukin-1 and tumor necrosis factor in disease // Nutrition.- 1995.- 11 Suppl.5.- p.695-697.
35. Ferrante A., Hauptmann B., Seckinger P., Dayer J.M. Ingibition of tumour necrosis factor alpha (TNFα)-induced neutrophil respiratory burst by a TNF inhibitor //Immunology.-1991.-V.72.-p.440-442.
36. Ferrara N. Vascular endothelial growth factor //Eur.J.of Cancer - 1996.-V.32A.-N.14.-p.2413-2422.
37. Ferrari R., Ceconi C., Curello S. et al. Protective effect of propionyl-L-carnitine against ischemia and reperfusion damage //Mol.Cell Biochem.-1989.-V.88.-p.161-168.
38. Ghezzi P., Dinarello C., Biamchi M., Rosamdich M., Repine J., White C.W. Hypoxia increases production of interleukin-1 and TNF by mononuclear cells // Cytokin.- 1991.- Vol.3.- p.189-194.
39. Gilmont R.R., Dardano A., Engle J.S. et al.TNF a- potentiates oxidant and reperfusion-induced endothelial cell injury //J.of Surg.Res.-1996.-V.G1.-N.1.-p.175-182.
40. Gotschlich E.C. C-reactive protein.A historical overview //Ann. New York Academy of sciences.-1992.-P.9-17.
41. Granger D.N., Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion (review) // J.Leukoc. Biol.- 1994.-V. 55.- p.662-675.
42. Gurfinkel E., Bozovich G., Beck E. et al. Treatment with the antibiotic roxithromycim in patients with acute non-Q-wave coronary syndromes; the final report of the ROXIS study //Eur.Heart J.-1999.-V.20.-N.2.-p.121-128.
43. Hardwick S.J., Hegyi L., Clare K. et al. Apoptosis in human monocyte-macrophages exposed to oxidised low-density lipoprotein //J.Pathol.-1996.-V.179.-p.294-302.
44. Harland W.A., Gilbert J.D., Brooks C.J.W. Lipids of human atheroma VIII. Oxidised derivatives of cholesteryl linoleate // Biochem Biophys Acta.-1973.-V.316.-p.378-385.
45. Hess M.L., Kukreja R. What are the prospects of antioxidants as a new therapeutic modality? //Dialogues in Cardiovasc.Med.-1998.- V.3.-N.1.-p.38-44.
46. Hisama N., Yamaguchi Y., Okajima K. et al. Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemattractant following ischemia-reperfusion //Digest. Dis. Sci.- -1996.- 41.- p.1481-1486.
47. Homeister J.W., Satoh P., Kilgore K.S., Lucchesi B.R. Soluble complement receptor type 1 prevents human complementmediated damage of the rabbit isolated heart //J.Immunol.-1993.- V.150.-p.1055-1064.
48. Horwitz L.D., Kaufman D., Kong Y. An antibody to leukocyte integrins attenuates coronary vascular injury due to ischemia and reperfusion in dogs //Am.J.Physiol.-1997.-V.272(2,pt 2).-p.H618-H624.
49. Ihling C., Gobel H.R., Lippoldt A. et al. Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: A detailed analysis of the cellular distribution of endotelin-1 //J.of Pathology.-1996.-V179.-N3.-p.303-308.
50. Inoue T., Sakai Y., Morooka S., Hayashi T., Takayanagi K., Nakabatake Y. Expression of PMN leukocyte adhesion molecules and its clinical significanse in patients treated with percutaneous transluminal coronary angioplasty //J. Amer. College Cardiol.-1996.- - 28.- p.1127-1133.
51. Kang Y.H., Brummel S.E., LeeC.H. Differential effects of transforming growth factor-a 1 on lipopolisaccharide induction of endothelial adhesion molecules //Shock.-1993.-V.6.-N.2.-p.118- 125.
52. Kerttula T., Riutta A., Kaukinen S. et al. Noradrenaline and dopamine infusions modulate arachidonic acid cyclooxygenase and 5-lipoxygenase pathways ex vivo in man //Prostagland. Leuk.,Essent.Fatty.- 1995.- 53.- p.47-52.
53. Koifman B., Wollman Y., Bogomolny N. et al. Improvment of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure //J.Am Coll Cardiol.-1995.- V.26.-N.5.-p.1251-1256.
54. Kristensen S.D., Ravn H.B., Falk E. Insights into the pathophysiology of unstable coronary artery disease //Am.J.Cardiol.- 1997.-V.80.-N.4.-p.E5-E9.
55. Kumar M., Liu G.J., Floyd R.A., Grammas P. Anoxic injury of endothelial cells increases production of nitric oxide and hydroxyl radicals //Biochemical and Biophysical Research Communications.- 1996.-V.219.-N.2.-p.497-501.
56. Lefer D.J., Flynn D.M., Buda A.J. Combined inhibition of P-selectin and ICAM-1 reduces myocardial injury following ischemia and reperfusion //Amer. J. Physiol.- Heart Circul. Physiol.-1996.- 40(6).- p.H2421-H2429.
57. Lender R., Oldgren J., Egberg N. et al. The effect of a low molecular mass thrombin inhibitor, inogatran and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease //Eur.Heart J.-1999.-V.20.-N.7.-p.506-419.
58. Lepran I., Lefer A.M. Ischemic aggravating effects of plateletactivating factor in acute myocardial ischemia //Basic Res. Cardiol.- 1985.- 80.- Р.135-141.
59. Lerman A., Holmes D.R.Jr., Itagane H. et al. Local release of endothelin in human coronary arteris in response to balloon angioplasty //J.Am Coll Cardiol.-1994.- N23 (Special Issue):124A.
60. Libby P. Molecular bases of the acute coronary syndromes //Ibid.- 1995.-V92.-p.2844-2850.
61. Lincoff A.M., Korngold S. An overview of platelet GP IIb/IIIa receptor antagonists trials //Eur.HeartJ.-1999.-V.20(suppl E).-p.E18-E27.
62. Loetscher H., Pan Y.C.E., Lahm H.W. et al. Molecular cloning and expression of the human 55 kD tumor necrosis factor receptor // Cell.-1990.-V.61.-p.351-360.
63. Luizzo G., Biasucci L.M., Gallimore J.R. et al. The prognostic value of C-reactive protein and serumamyloid A protein in severe unstable angina //N.Engl.J.Med.-1994.-N.331.-p.417-424.
64. Luscher T.F., Noll G. Endothelium dysfunction in the coronary circulation //J. Cardiovasc. Pharmacol.-1994.-V.24(Suppl.3).-p.16-26.
65. Macdonald P.S., Read M.A., Dusting G.J. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin //Tromb. Res.-1988.-V.48.-p.437.
66. Madan M., Berkowitz S.D., Tcheng J.E. Glycoprotein IIb//III integrin blockads //Circulation. -1998.- V.98.-p.2629-2635.
67. Mantovani A., Bussolino F., Dejana E. Cytokine regulation of endothelial cell function // FASEB J.- 1992.- V.6.-p.2591-2599.
68. Marchant C.E., van der Veen C., Law N.S. et al. Oxidation of lowdensity lipoprotein by human monocyte-macrophages results in toxicity to the oxidising culture //Free Radic.Res.-1996.-V.24.-p.333-342.
69. Maseri A. Antibiotics for acute coronary syndromes: are we ready for magatrials? //Eur.Heart J.-1999.-V.20.-N.2.-p.89-93.
70. McKee P.A. Hemostasis and disorders of blood coagulation. In: The Metabolic Basis of Inherited Disease, 5th ed., Stanbury J.B. et al. (eds.), McGraw-Hill,1983.
71. Mehta J., Dinerman J., Mehta P. et al. Neutrophil function in ischemic heart disease // Circulation.- 1989.- 79.-p.549-556.
72. Milazzo V.J., Ferrante R.J., Sabido F., Silva M.B., Hobson R.W,., Dunan W. Time course of leukocyte adhesion to endothelium in ischemia-reperfusion //J.Surgical Res.- 1996.-V. 61.- p.139-142.
73. Missov E., Cambell A., Lebel B. Cytokine inhibitors in patients with heart failure and impaired functional capacity //Jpn.Circ.J.-1997.- V.61.-N.9.-P.749-754.
74. Miura T., Nelson D.P., Schermerhorn M.L. et al. Blockade of selectinmediated leukocyte adhesion improves postischemic function in lamb hearts //Ann. Thoracic Surgery.- 1996.-V.62.-p. 1295-1300.
75. Momboli J.V., Vanhoutte P.M. Endothelial function after convertingenzyme inhibition //Medicographia.- 1996.-V.18.-N1.-P.35-40.
76. Nilson T., Cantera L., Adner M., Edvinsson L. Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries //Neurosurgery.-1997.-V.40.-N.2.-p.346-351.
77. Orgaard O.S., Cantera L., Adner M., Edvinsson L. Endothelin-A and -B receptors in human coronary arteries and veins //Regulatory Peptides.-1996.-V.63.-N5.-p.149-156.
78. Pabla R., Buda A., Flynn D. et al. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and repetfusion //Circ Res.-1996.-V.78.-p.65-72.
79. Pradier O., Gerarad C., Delvaux A. et al. Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide //Eur.J.Immunol.-1993.-V.23.-p.2700-2703.
80. Rapola J.M., Virtamo J., Huttunen J.K. Antioxidants and ischaemic heart disease //Lancet.-1997.-V.350(9078).-p.668.
81. Raschke P. Massoudy P., Becker B.F. Taurine protects the heart from neutrophil-induced reperfusion injury //Free Radical Biol. Med.- 1995.-V.19.- p.461-471.
82. Redmond E.M., Gahill P., Hodges R. et al., Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells //J. Cell Physiol.-1996.-V.166.-N.3.-p.469-479.
83. Ross R. Endothelial dysfunction and atherosclerosis, ed by N.Simionescu and M.Simionescu.Plenum Press, New York,1992.-p.295-307.
84. Saijonmaa O., Ristimaki A., Fyhrquist F. Atrial natriuretic peptide, nitroglycerine,and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells //Biochem Biophys Res Commun.-1990.- V.173.-p.514.
85. Saikku P., Mattila K. et al. Serological evidence of an association of novel Chlamydia, TWAR, with coronary heart disease and acute myocardial infarction //Lancet.-1998.-N.2.-p.983-986.
86. Sakurawi K., Yasuda F., Tozyo T. et al. Endothelin receptor antagonist triterpenoid,myriceric acid A, isolated from Myrica cerifera, and structure activity relationships of its derivatives // Chem.and Pharmacol.Bull.-1996.-V.44.-N.2.-p.343-351.
87. Samanen J. GPIIb/IIIa antagonists //Ann. Rep.Med.Chem.-1996.- V.31.- p.91-100.
88. Satre H., Holmvang L., Wager G.S. et al. Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease //Eur.Heart J.- 1999.-V.20.-N.9.-p.645-653.
89. Schmidt F.E., Macdonald M.J., Murphy C.O., Brown W.M., Gott J.P., Guyton R.A. Leukocyte depletion of blood cardioplegia attenuates reperfusion injury //Ann. Thoracic Surgery.- 1996.- V.62. - p. 1691-1696.
90. Serrano C.V., Mikhail E.A., Wany P.H., Noble B. Kuppusamy P. Superoxide and hydrogen peroxide induce CD18-mediated adhesion in the postischemic heart //Biochim Biophys Acta.-1996.-V.316.-p.191-202.
91. Simpson P.J., Todd 3d,J.K., Mickelson J.C. et al. Sustained limitation of myocardial reperfusion injury by a monoclomal antibody that alters leukocyte function //Dialogues in Cardivasc.Med.-1998.-V.3.-N.1.-p.54.
92. Stenberg D. Oxidative modification of LDL and atherogenesis // Circulation.-1997.-N.95.-p.1062-1071.
93. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation and ischemia-reperfusion injury //Shock.-1996.-N.6.- p. 79-88.
94. The Investigators of the Study on propionyl-L-carnitine in heart failure. Study on prorionyl-L-carnitine in chronic heart failure // Eur.Heart J.-1999.-V.20.-N.1.-p.70-77.
95. Tonnessen T., Ilebekk A., Naess P., Christensen G. Inhibition of granulocyte-derived proteases reduces the increase in plasma endothelin associated with myocardial ischemia in the pig //Basic Res. Cardiol.- 1996.- V.91.- p.289-295.
96. Toopl E.J., Ferguson J.J., Wesman H.F. et al. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin b3 blocade with percutaneous coronary intervention: EPIC investigator Group: Evaluation of platelet IIb/IIIa ingimition for ptevention of ischemic complication //JAMA.-1997.-V.278.-p.479-484.
97. Verheggen P.W.H.M., de Maat M.P.M., Manger Cats V. et al. Inflammatory status as a main deterninant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function //Eur.Heart J.-1999.-V15.-N.9.-p.415-420.
98. Vitola J.V., Forman M.B., Holsinger J.P. et al. Role of endothelin in a rabbit model of acute myocardial infarction: effects of receptor antagonists //J.Cardiovasc Pharmacol.-1996.-V.28.-p.774-783.
99. Wallen N.H., Held C., Rehnqvist N., Hjemdahl P. Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule- 1 among patients with stable angina pectoris who suffer cardiovascular death or nonfatal myocardial infarction //Eur.Heart J.-1999.-V.20.-N.14.-p.1039-1044.
100. Wattiaux R., Jadot M., Warnierpirotte M.T., Wattiauxdeconinck S. Cationic lipids destabilize lysosomal membrane in vitro // FEBS Letters.-1997.-V.417.-N.2.-p. 199-202
101. Yang B.C., Chen L.Y., Saldeen T.G.P., Mehta J.L. Reperfusion injury in the endotoxin-treated rat heart: Reevaluation of the role of nitric oxide //British J.Pharmacol.-1997.-V.120.-N.2.-p.305-311.
102. Yuan X.M., Li W., Olsson A.G., Brunk U.T., The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage.//Atherosclerosis.- 1997.-V.133.-N.2.-p.153-161.
103. Yudkin J.S. Coronary heart disease in diabetes mellitus: Three new risk factors and a unifying hypothesis //J.Internal Med.-1995.- V.238.-N.1.-p.21-30.
104. Zaugg C.E., Hornstein P.S., Zhu P.L. et al. Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts //Circulation.- 1996.-V.94.-N.4.-p.742-747.
105. Ziff M. Role of endothelium in chronic inflammation //Springer Semin Immunopathol.-1989.-V.1.-p.199-214.
Рецензия
Для цитирования:
Маянская С.Д., Куимов А.Д. ЭНДОТЕЛИАЛЬНАЯ ДИСФУНКЦИЯ И ОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ. Российский кардиологический журнал. 2001;(2):76-84.
For citation:
Mayanskaya S.D., Kuimov A.D. ENDOTHELIAL DYSFUNCTION AND ACUTE CORONARY SYNDROME. Russian Journal of Cardiology. 2001;(2):76-84. (In Russ.)
Просмотров:
448
Послать статью по эл. почте 